EUCTR2009-011452-21-GB进行中（未招募）1 期
Study of the effectiveness of Voriconazole in the treatment of Aspergillus fumigatus associated asthma - Effectiveness of Voriconazole in Aspergillus associated asthma
niversity Hospitals of Leicester NHS trust0 个研究点目标入组 0 人开始时间: 2009年7月23日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •Inclusion criteria
- •Aged 18 and over
- •Able to give consent
- •Diagnosis of asthma and fungal sensitization or allergic bronchopulmonary aspergillosis.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Exclusion criteria
- •Age under 18
- •Unable to give informed consent
- •A principle diagnosis of COPD or bronchiectasis
- •History of non compliance with medication, or unable to produce sputum.
- •A co-morbid condition likely to increase the risk of side effects
- •Pregnancy or possibility of becoming pregnant during the treatment phase of the study.
研究者
相似试验
已完成
不适用
Study of the effectiveness of voriconazole in the treatment of Aspergillus fumigatus associated asthmaAsthmaRespiratoryISRCTN42366088niversity Hospitals of Leicester NHS Trust (UK)70
招募中
4 期
comparative evaluation of oral voriconazole and oral ketoconazole in severe fungal keratitisCTRI/2016/07/007103DR R P Centre AIIMS New Delhi40
已完成
3 期
An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal InfectionsFungemiaMycosesCandidiasisAspergillosisNCT00001810National Cancer Institute (NCI)300
进行中（未招募）
不适用
Dosing of voriconazole according to the package leaflet compared with dosing voriconazole based on measured voriconazole concentrations in blood.EUCTR2008-007973-19-DEniversity Medical Center Groningen192
进行中（未招募）
不适用
Pharmacologic optimization of voriconazole - a prospective clustered group-randomized cross-over trial of therapeutic drug monitoringThe objective of this prospective stratified cluster randomized cross-over trial is to determine whether pharmacologic optimization of voriconazole by means of therapeutic drug monitoring (TDM) results in improved outcome in patient with haematological malignancies (efficacy and safety) and is more cost-effective compared to the current standard of care.EUCTR2008-007973-19-NLniversity Medical Center Groningen192